Bone Marrow Transplantation Journal Citation Rate 2026

ISSN 0268-3369 eISSN 1476-5365 Springer Nature GB

Q2 Quartile Established Impact

About Bone Marrow Transplantation
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Bone Marrow Transplantation (BMT) is a peer-reviewed academic journal covering Acute Lymphoblastic Leukemia research and Acute Myeloid Leukemia Research, published by Springer Nature in GB, catalogued under ISSN 0268-3369 (e-ISSN 1476-5365). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.73 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4480 USD). OpenAlex records 11,970 works and 343,740 citations, with an h-index of 171.

Bone Marrow Transplantation Citation Rate 2026 — In Context

Bone Marrow Transplantation has a 2025 2-Year Citation Rate (OpenAlex) of 2.73, placing it in the Q2 quartile within the Acute Lymphoblastic Leukemia research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Bone Marrow Transplantation operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Bone Marrow Transplantation should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Bone Marrow Transplantation against similar journals in the field, use our journal comparison tool.

Submission Tips for Bone Marrow Transplantation
  • Budget $4480 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Bone Marrow Transplantation Compares
Citation Rate vs Field Avg
-37%
Field avg: 4.33
APC vs Field Avg
+23%
Field avg: $3641

Compared against 48 journals in the same research areas.

ISSN (Print) 0268-3369
ISSN (Online) 1476-5365
Publisher Springer Nature
Country United Kingdom
APC / Cost $4480 USD
In-depth profile & metrics

Bone Marrow Transplantation is published by Springer Nature and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 4480.

In our subject taxonomy, Bone Marrow Transplantation is classified under Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation and Immune Cell Function and Interaction.

Bone Marrow Transplantation is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 2.729.

Research Areas
Links
Frequently Asked Questions about Bone Marrow Transplantation

Bone Marrow Transplantation does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 2.729 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Bone Marrow Transplantation is not an open access journal.

The Article Processing Charge (APC) for Bone Marrow Transplantation is $4480 USD.

Bone Marrow Transplantation is published by Springer Nature.

Bone Marrow Transplantation shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Bone Marrow Transplantation is 0268-3369. Its electronic ISSN (eISSN) is 1476-5365.

Bone Marrow Transplantation sits in the Q2 quartile based on its latest impact factor of 2.73, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
2.729
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 2.729 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Compare Journals

Compare Bone Marrow Transplantation against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S183182149

Get weekly updates for Acute Lymphoblastic Leukemia research journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google